THE SANOFI PASTEUR INFLUENZA VACCINE PORTFOLIO 2019 …

THE SANOFI PASTEUR INFLUENZA VACCINE PORTFOLIO

SIMPLIFY YOUR INFLUENZA VACCINE CHOICES FOR PERSONS 6 MONTHS OF AGE AND OLDER

Packaging

Syringes and Vials

Ages1-3

Presentation1-3

Dosing Schedule1-4

CPT?a Codes and Coverage5

65 years

of age and older

0.5-mL

prefilled syringe

1 dose

90662

Covered by most health plans and Medicare Part B

2019-2020 SEASON

NDCb Information5

Package NDC

Unit NDC

49281-0405-65

49281-0405-88

EMRc Code

18 years

of age and older

0.5-mL

prefilled syringe

1 dose

90682

Covered by most health plans and Medicare Part B

49281-0719-10

49281-0719-88

6 months through 35 months

of age

0.25-mL

prefilled syringe (pediatric dose)

90685

Covered by most health plans and Medicare Part B

49281-0519-25

0.25-mL prefilled syringe (pediatric dose)

49281-0519-00

0.25-mL prefilled syringe (pediatric dose)

6 months

of age and older

6 months

of age and older

0.5-mL

prefilled syringe

0.5-mL

single-dose vial

5-mL

multidose vial

1 or 2 doses

Per Advisory Committee on Immunization Practices (ACIP) guidance, children 6 months through 8 years of age require 2 doses of influenza vaccine (given at least 4 weeks apart) in the flu season, if they are considered inadequately primed.

90686

Covered by most health plans and Medicare Part B

90687 (0.25-mL dose)

Covered by most health plans and Medicare Part B

90688 (0.5-mL dose)

Covered by most health plans and Medicare Part B

49281-0419-50

0.5-mL prefilled syringe

49281-0419-10

0.5-mL single-dose vial

49281-0631-15

5-mL multidose vial

49281-0419-88

0.5-mL prefilled syringe

49281-0419-58

0.5-mL single-dose vial

49281-0631-78

5-mL multidose vial

a CPT (Current Procedural Terminology) is a registered trademark of the American Medical Association. b NDC = National Drug Code. c EMR = Electronic medical record.

INDICATION FOR FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT, AND FLUZONE HIGH-DOSE VACCINES

Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines are indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B virus(es) contained in each vaccine. Flublok Quadrivalent vaccine is approved for use in persons 18 years of age and older. Fluzone Quadrivalent vaccine is approved for use in persons 6 months of age and older. Fluzone High-Dose vaccine is approved for use in persons 65 years of age and older.

IMPORTANT SAFETY INFORMATION FOR FLUBLOK QUADRIVALENT, FLUZONE QUADRIVALENT, AND FLUZONE HIGH-DOSE VACCINES

Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine (including egg protein for Fluzone Quadrivalent and Fluzone High-Dose vaccines) or after a previous dose of the respective vaccine. In addition, Fluzone Quadrivalent and Fluzone High-Dose vaccines should not be administered to anyone who has had a severe allergic reaction after a previous dose of any influenza vaccine.

If Guillain-Barr? syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine should be based on careful consideration of the potential benefits and risks.

In adults, the most common local and systemic adverse reactions to Flublok Quadrivalent, Fluzone Quadrivalent, and Fluzone High-Dose vaccines include pain at the injection site; headache and myalgia. In children, the most common reactions to Fluzone Quadrivalent vaccine include pain, erythema, and swelling at the injection site; myalgia, malaise, and headache (irritability, abnormal crying, drowsiness, appetite loss, vomiting, and fever in young children). Other adverse reactions to these vaccines may occur. Vaccination with Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine may not protect all individuals.

Before administration, please see the full Prescribing Information for Flublok Quadrivalent, Fluzone Quadrivalent, or Fluzone High-Dose vaccine.

References: 1. Fluzone High-Dose vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc. 2. Flublok Quadrivalent vaccine [Prescribing Information]. Meriden, CT: Protein Sciences Corporation. 3. Fluzone Quadrivalent vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc. 4. Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices--United States, 2018?19 influenza season. MMWR. 2018;67(3):1-20. 5. Sanofi Pasteur Inc. Data on file, 2019.

SANOFI PASTEUR. Discovery Drive. Swiftwater, Pennsylvania 18370. sanofipasteur.us

SAUS.SFLU.19.03.1821

?2019SanofiPasteurInc.

3/19

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download